The global market for Clindamycin Phosphate for Injection was valued at US$ 48.1 million in the year 2024 and is projected to reach a revised size of US$ 67.9 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Clindamycin phosphate for injection is a broad-spectrum antibiotic belonging to the lincosamide class of antibacterial drugs, mainly used to treat severe infections caused by sensitive anaerobic bacteria and certain Gram-positive aerobic bacteria. It exerts its antibacterial effect by inhibiting bacterial protein synthesis and is suitable for the treatment of a variety of infectious diseases such as pneumonia, sepsis, intra-abdominal infection, osteomyelitis, etc. The drug is provided in the form of phosphate, which is convenient for intravenous or intramuscular administration and can be rapidly converted into the active metabolite clindamycin in the body, ensuring rapid onset of action and maintaining a stable blood drug concentration.
North American market for Clindamycin Phosphate for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Clindamycin Phosphate for Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Clindamycin Phosphate for Injection include Jiangxi Pharmaceutical Co., Ltd., Inner Mongolia Baiyi Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd., Jiangsu Aosaikang Pharmaceutical Co., Ltd., Hainan Lingkang Pharmaceutical Co., Ltd., Shanghai Fudan Fuhua Pharmaceutical Co., Ltd., Shanxi Pude Pharmaceutical Co., Ltd., Zhejiang Zuoli Pharmaceutical Co., Ltd., Hainan Jinrui Pharmaceutical Co., Ltd., Hainan Huluwa Pharmaceutical Group Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Clindamycin Phosphate for Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clindamycin Phosphate for Injection.
The Clindamycin Phosphate for Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Clindamycin Phosphate for Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clindamycin Phosphate for Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Jiangxi Pharmaceutical Co., Ltd.
Inner Mongolia Baiyi Pharmaceutical Co., Ltd.
Southwest Pharmaceutical Co., Ltd.
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Hainan Lingkang Pharmaceutical Co., Ltd.
Shanghai Fudan Fuhua Pharmaceutical Co., Ltd.
Shanxi Pude Pharmaceutical Co., Ltd.
Zhejiang Zuoli Pharmaceutical Co., Ltd.
Hainan Jinrui Pharmaceutical Co., Ltd.
Hainan Huluwa Pharmaceutical Group Co., Ltd.
Jiangsu Jiuxu Pharmaceutical Co., Ltd.
Sinopharm Group Guorui Pharmaceutical Co., Ltd.
Zhuhai Yibang Pharmaceutical Co., Ltd.
Jilin Aodong Taonan Pharmaceutical Co., Ltd.
Segment by Type
0.5g (Calculated as C18H33C1N2O5S)
0.9g (Calculated as C18H33C1N2O5S)
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Clindamycin Phosphate for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Clindamycin Phosphate for Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Clindamycin Phosphate for Injection Market Overview
1.1 Product Definition
1.2 Clindamycin Phosphate for Injection by Type
1.2.1 Global Clindamycin Phosphate for Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 0.5g (Calculated as C18H33C1N2O5S)
1.2.3 0.9g (Calculated as C18H33C1N2O5S)
1.3 Clindamycin Phosphate for Injection by Application
1.3.1 Global Clindamycin Phosphate for Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Clindamycin Phosphate for Injection Market Size Estimates and Forecasts
1.4.1 Global Clindamycin Phosphate for Injection Revenue 2020-2031
1.4.2 Global Clindamycin Phosphate for Injection Sales 2020-2031
1.4.3 Global Clindamycin Phosphate for Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Clindamycin Phosphate for Injection Market Competition by Manufacturers
2.1 Global Clindamycin Phosphate for Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Clindamycin Phosphate for Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Clindamycin Phosphate for Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Clindamycin Phosphate for Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Clindamycin Phosphate for Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Clindamycin Phosphate for Injection, Product Type & Application
2.7 Global Key Manufacturers of Clindamycin Phosphate for Injection, Date of Enter into This Industry
2.8 Global Clindamycin Phosphate for Injection Market Competitive Situation and Trends
2.8.1 Global Clindamycin Phosphate for Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Clindamycin Phosphate for Injection Players Market Share by Revenue
2.8.3 Global Clindamycin Phosphate for Injection Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Clindamycin Phosphate for Injection Market Scenario by Region
3.1 Global Clindamycin Phosphate for Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Clindamycin Phosphate for Injection Sales by Region: 2020-2031
3.2.1 Global Clindamycin Phosphate for Injection Sales by Region: 2020-2025
3.2.2 Global Clindamycin Phosphate for Injection Sales by Region: 2026-2031
3.3 Global Clindamycin Phosphate for Injection Revenue by Region: 2020-2031
3.3.1 Global Clindamycin Phosphate for Injection Revenue by Region: 2020-2025
3.3.2 Global Clindamycin Phosphate for Injection Revenue by Region: 2026-2031
3.4 North America Clindamycin Phosphate for Injection Market Facts & Figures by Country
3.4.1 North America Clindamycin Phosphate for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Clindamycin Phosphate for Injection Sales by Country (2020-2031)
3.4.3 North America Clindamycin Phosphate for Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Clindamycin Phosphate for Injection Market Facts & Figures by Country
3.5.1 Europe Clindamycin Phosphate for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Clindamycin Phosphate for Injection Sales by Country (2020-2031)
3.5.3 Europe Clindamycin Phosphate for Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Clindamycin Phosphate for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Clindamycin Phosphate for Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Clindamycin Phosphate for Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Clindamycin Phosphate for Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Clindamycin Phosphate for Injection Market Facts & Figures by Country
3.7.1 Latin America Clindamycin Phosphate for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Clindamycin Phosphate for Injection Sales by Country (2020-2031)
3.7.3 Latin America Clindamycin Phosphate for Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Clindamycin Phosphate for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Clindamycin Phosphate for Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Clindamycin Phosphate for Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Clindamycin Phosphate for Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Clindamycin Phosphate for Injection Sales by Type (2020-2031)
4.1.1 Global Clindamycin Phosphate for Injection Sales by Type (2020-2025)
4.1.2 Global Clindamycin Phosphate for Injection Sales by Type (2026-2031)
4.1.3 Global Clindamycin Phosphate for Injection Sales Market Share by Type (2020-2031)
4.2 Global Clindamycin Phosphate for Injection Revenue by Type (2020-2031)
4.2.1 Global Clindamycin Phosphate for Injection Revenue by Type (2020-2025)
4.2.2 Global Clindamycin Phosphate for Injection Revenue by Type (2026-2031)
4.2.3 Global Clindamycin Phosphate for Injection Revenue Market Share by Type (2020-2031)
4.3 Global Clindamycin Phosphate for Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Clindamycin Phosphate for Injection Sales by Application (2020-2031)
5.1.1 Global Clindamycin Phosphate for Injection Sales by Application (2020-2025)
5.1.2 Global Clindamycin Phosphate for Injection Sales by Application (2026-2031)
5.1.3 Global Clindamycin Phosphate for Injection Sales Market Share by Application (2020-2031)
5.2 Global Clindamycin Phosphate for Injection Revenue by Application (2020-2031)
5.2.1 Global Clindamycin Phosphate for Injection Revenue by Application (2020-2025)
5.2.2 Global Clindamycin Phosphate for Injection Revenue by Application (2026-2031)
5.2.3 Global Clindamycin Phosphate for Injection Revenue Market Share by Application (2020-2031)
5.3 Global Clindamycin Phosphate for Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Jiangxi Pharmaceutical Co., Ltd.
6.1.1 Jiangxi Pharmaceutical Co., Ltd. Company Information
6.1.2 Jiangxi Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Jiangxi Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Jiangxi Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Product Portfolio
6.1.5 Jiangxi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Inner Mongolia Baiyi Pharmaceutical Co., Ltd.
6.2.1 Inner Mongolia Baiyi Pharmaceutical Co., Ltd. Company Information
6.2.2 Inner Mongolia Baiyi Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Inner Mongolia Baiyi Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Inner Mongolia Baiyi Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Product Portfolio
6.2.5 Inner Mongolia Baiyi Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Southwest Pharmaceutical Co., Ltd.
6.3.1 Southwest Pharmaceutical Co., Ltd. Company Information
6.3.2 Southwest Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Southwest Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Southwest Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Product Portfolio
6.3.5 Southwest Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Jiangsu Aosaikang Pharmaceutical Co., Ltd.
6.4.1 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Company Information
6.4.2 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Product Portfolio
6.4.5 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Hainan Lingkang Pharmaceutical Co., Ltd.
6.5.1 Hainan Lingkang Pharmaceutical Co., Ltd. Company Information
6.5.2 Hainan Lingkang Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Hainan Lingkang Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hainan Lingkang Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Product Portfolio
6.5.5 Hainan Lingkang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd.
6.6.1 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Company Information
6.6.2 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Product Portfolio
6.6.5 Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Shanxi Pude Pharmaceutical Co., Ltd.
6.7.1 Shanxi Pude Pharmaceutical Co., Ltd. Company Information
6.7.2 Shanxi Pude Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Shanxi Pude Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Shanxi Pude Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Product Portfolio
6.7.5 Shanxi Pude Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Zhejiang Zuoli Pharmaceutical Co., Ltd.
6.8.1 Zhejiang Zuoli Pharmaceutical Co., Ltd. Company Information
6.8.2 Zhejiang Zuoli Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Zhejiang Zuoli Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Zhejiang Zuoli Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Product Portfolio
6.8.5 Zhejiang Zuoli Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 Hainan Jinrui Pharmaceutical Co., Ltd.
6.9.1 Hainan Jinrui Pharmaceutical Co., Ltd. Company Information
6.9.2 Hainan Jinrui Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Hainan Jinrui Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hainan Jinrui Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Product Portfolio
6.9.5 Hainan Jinrui Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Hainan Huluwa Pharmaceutical Group Co., Ltd.
6.10.1 Hainan Huluwa Pharmaceutical Group Co., Ltd. Company Information
6.10.2 Hainan Huluwa Pharmaceutical Group Co., Ltd. Description and Business Overview
6.10.3 Hainan Huluwa Pharmaceutical Group Co., Ltd. Clindamycin Phosphate for Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Hainan Huluwa Pharmaceutical Group Co., Ltd. Clindamycin Phosphate for Injection Product Portfolio
6.10.5 Hainan Huluwa Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.11 Jiangsu Jiuxu Pharmaceutical Co., Ltd.
6.11.1 Jiangsu Jiuxu Pharmaceutical Co., Ltd. Company Information
6.11.2 Jiangsu Jiuxu Pharmaceutical Co., Ltd. Description and Business Overview
6.11.3 Jiangsu Jiuxu Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Jiangsu Jiuxu Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Product Portfolio
6.11.5 Jiangsu Jiuxu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Sinopharm Group Guorui Pharmaceutical Co., Ltd.
6.12.1 Sinopharm Group Guorui Pharmaceutical Co., Ltd. Company Information
6.12.2 Sinopharm Group Guorui Pharmaceutical Co., Ltd. Description and Business Overview
6.12.3 Sinopharm Group Guorui Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sinopharm Group Guorui Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Product Portfolio
6.12.5 Sinopharm Group Guorui Pharmaceutical Co., Ltd. Recent Developments/Updates
6.13 Zhuhai Yibang Pharmaceutical Co., Ltd.
6.13.1 Zhuhai Yibang Pharmaceutical Co., Ltd. Company Information
6.13.2 Zhuhai Yibang Pharmaceutical Co., Ltd. Description and Business Overview
6.13.3 Zhuhai Yibang Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Zhuhai Yibang Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Product Portfolio
6.13.5 Zhuhai Yibang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.14 Jilin Aodong Taonan Pharmaceutical Co., Ltd.
6.14.1 Jilin Aodong Taonan Pharmaceutical Co., Ltd. Company Information
6.14.2 Jilin Aodong Taonan Pharmaceutical Co., Ltd. Description and Business Overview
6.14.3 Jilin Aodong Taonan Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Jilin Aodong Taonan Pharmaceutical Co., Ltd. Clindamycin Phosphate for Injection Product Portfolio
6.14.5 Jilin Aodong Taonan Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Clindamycin Phosphate for Injection Industry Chain Analysis
7.2 Clindamycin Phosphate for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Clindamycin Phosphate for Injection Production Mode & Process Analysis
7.4 Clindamycin Phosphate for Injection Sales and Marketing
7.4.1 Clindamycin Phosphate for Injection Sales Channels
7.4.2 Clindamycin Phosphate for Injection Distributors
7.5 Clindamycin Phosphate for Injection Customer Analysis
8 Clindamycin Phosphate for Injection Market Dynamics
8.1 Clindamycin Phosphate for Injection Industry Trends
8.2 Clindamycin Phosphate for Injection Market Drivers
8.3 Clindamycin Phosphate for Injection Market Challenges
8.4 Clindamycin Phosphate for Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Jiangxi Pharmaceutical Co., Ltd.
Inner Mongolia Baiyi Pharmaceutical Co., Ltd.
Southwest Pharmaceutical Co., Ltd.
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Hainan Lingkang Pharmaceutical Co., Ltd.
Shanghai Fudan Fuhua Pharmaceutical Co., Ltd.
Shanxi Pude Pharmaceutical Co., Ltd.
Zhejiang Zuoli Pharmaceutical Co., Ltd.
Hainan Jinrui Pharmaceutical Co., Ltd.
Hainan Huluwa Pharmaceutical Group Co., Ltd.
Jiangsu Jiuxu Pharmaceutical Co., Ltd.
Sinopharm Group Guorui Pharmaceutical Co., Ltd.
Zhuhai Yibang Pharmaceutical Co., Ltd.
Jilin Aodong Taonan Pharmaceutical Co., Ltd.
听
听
*If Applicable.